Peer-reviewed studyPNAS
Heavily mutated SARS-CoV-2 variant may escape some antibodies, study suggests
A peer-reviewed study in PNAS by Priscilla Turelli and colleagues examines BA.2.87.1, a variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with many mutations in its spike protein. The authors report that changes to its N-terminal domain weaken the ability of human convalescent antibodies to engage it, which may reduce protection.
- Published
- Oct 28, 2026
DOI 10.1073/pnas.2608185123
Peer-reviewed studyCell
Viral replication needs a threshold of viral genomes, study in Cell finds
A peer-reviewed study in Cell reports that viral replication requires more than one unit of viral genomes, a threshold that varies with the virus and cell type. The authors say these genome levels switch on negative feedback regulators of innate immune sensors, which suppresses the immune response and allows replication.
- Published
- Oct 29, 2026
DOI 10.1016/j.cell.2026.10.004
Preprint, not peer-reviewedmedRxiv
Preprint compares ways to spot epidemic outbreaks from routine blood tests
A preprint on medRxiv, not yet reviewed by other scientists, compares statistical methods for detecting an epidemic from routinely collected blood test results. Using simulated data and real-world C-reactive protein (CRP) data from Russia, the authors report that the methods' performance depends on how much data is available. Composite biomarkers from complete blood count (CBC) results increased the chance of detecting an outbreak compared with CRP alone.
- Published
- Oct 29, 2026
DOI 10.64898/2026.10.27.26364498
Preprint, not peer-reviewedmedRxiv
Preprint reports one AI model completing thousands of medical prediction tasks
A preprint on medRxiv, not yet reviewed by other scientists, describes PhenOM, a generative artificial intelligence (AI) foundation model trained on longitudinal medical-event data from more than 400 million patient records. The authors report that the single model has been used to complete and validate thousands of predictive tasks covering more than 1,770 outcomes. They say 80 percent of tasks reached an area under the receiver operating characteristic curve (AUROC) of at least 0.70, and 30 percent reached at least 0.80.
- Published
- Oct 29, 2026
DOI 10.64898/2026.10.28.26366723
Preprint, not peer-reviewedbioRxiv
Preprint explains how a new compound stalls coronavirus RNA polymerase
A preprint on bioRxiv, not yet reviewed by other scientists, examines 6-ethyl-modified 7-deazaadenosine (EDA), an inhibitor of coronaviruses. The authors report that EDA is incorporated by the coronavirus RNA-dependent RNA polymerase (RdRp) as a mimic of one natural building block, stalling it, and they say it does not induce virus mutagenesis. They tested the mechanism with cryo-EM structures, antiviral studies and mutant viruses.
- Published
- Oct 29, 2026
DOI 10.64898/2026.10.28.761875
Preprint, not peer-reviewedbioRxiv
Preprint proposes societal safety levels for research on pandemic pathogens
A preprint on bioRxiv, not yet reviewed by other scientists, by K. M. Esvelt and colleagues proposes adding Societal Safety Levels (SSLs) to biosafety levels. The SSLs would set thresholds for expected public fatalities per year and would apply only to laboratory research with replication-competent potential pandemic pathogens. The authors say applying a standard of 0.1 expected deaths per facility-year would require marked safety improvements.
- Published
- Oct 29, 2026
DOI 10.64898/2026.10.28.762599
Final rule, effective Jan 1, 2027Centers for Medicare & Medicaid Services
Medicare updates 2027 payment rules for kidney dialysis facilities
The Centers for Medicare & Medicaid Services (CMS), within the Health and Human Services Department, has issued a final rule updating the End-Stage Renal Disease (ESRD) Prospective Payment System for calendar year 2027. The rule also updates the payment rate for dialysis services furnished to individuals with acute kidney injury, and the ESRD Quality Incentive Program. It takes effect on January 1, 2027.
- Published
- Oct 30, 2026
- Effective
- Jan 1, 2027
How to weigh in: No comment period: this is a final rule.
FR Doc. 2026-22194 · CMS-1846-F
ProposedCalifornia Department of Public Health
California proposes permanent hospice rules to curb fraud and set care standards
The California Department of Public Health (CDPH) proposes to permanently adopt emergency regulations for hospice agencies, setting patient care and business practice standards. The proposal would adopt nurse-to-patient staffing ratios, limit hospices to care in specified Geographical Service Areas, and require detailed background information for prospective owners and administrators. The Department says these measures aim to combat Medicare and Medi-Cal fraud.
- Published
- Oct 30, 2026
- Comments close
- Dec 14, 2026
How to weigh in: Comment by December 14, 2026.
Notice File Number Z2026-1016-01
In effectTexas Health and Human Services Commission
Texas rule lowers minimum inspection frequency to once every three years
The Texas Health and Human Services Commission (HHSC) has adopted an amendment to section 550.1301 of its rules on inspections and visits. It reduces inspections from annually to at least once every three years, to align with licensure renewal timeframes, and reduces administrative and operational burdens for providers. The rule takes effect on November 2, 2026.
- Published
- Oct 30, 2026
- Effective
- Nov 2, 2026
How to weigh in: No comment period: this is a final rule.
TRD-202604355
Preprint, not peer-reviewedmedRxiv
Preprint reports an influenza booster may cut weak antibody responses
A preprint on medRxiv, not yet reviewed by other scientists, by S. Orsinelli-Rivers and colleagues reports a phase 4 clinical trial of a heterologous prime-boost, in which the booster contains an updated H3N2 strain. The authors say the booster reduced the proportion of people with negligible antibody responses, with no H3N2 non-responders among those who received the prime and boost, compared with 29% for H1N1. They suggest multi-strain exposures may reduce the share of people who do not mount an antibody response in a season.
- Published
- Oct 30, 2026
DOI 10.64898/2026.10.28.26366744
Preprint, not peer-reviewedbioRxiv
Preprint describes a 'duality' vaccine design aimed at steering antibodies
A preprint on bioRxiv, not yet reviewed by other scientists, by G. Admans and colleagues describes 'Duality vaccination', which delivers activating and inhibitory immunogens together to focus antibody responses. The authors say the design can tailor elicited antibodies to down-modulate undesired B cell responses. They say the effects depend on timing, spacing, valency and linker flexibility, and they tested it with model targets and coronavirus antigens.
- Published
- Oct 30, 2026
DOI 10.64898/2026.10.28.762652